University of Arizona Health Sciences, University of Pennsylvania and Vanderbilt University researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and to identifying new drug targets and therapies.Continue reading→

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced today that it has entered into a definitive agreement to acquire Scottsdale, Arizona-based Cayenne Medical, Inc. The transaction, which is subject to customary closing conditions, is expected to close during the second quarter of 2016. The financial terms of the transaction were not disclosed.  Continue reading→

Phoenix, AZ – April 25, 2016: Beacon Biomedical, Inc., a privately held company focused on developing highly accurate laboratory and point-of-care blood tests for early colorectal cancer screening, announced that it has appointed Dave English as Director of Business Development.Continue reading→

Latest in genomic technologies could track sources of future infectious outbreaksContinue reading→

Standardized and Pooled Data Available for Secondary ResearchContinue reading→

The Critical Path Institute (C-Path), the Special Programme for Research and Training in Tropical Diseases (TDR), TB Alliance, and St. George’s, University of London, are pleased to announce the launch of the TB-Platform for Aggregation of Clinical TB Studies (TB-PACTS).Continue reading→

Mattress Firm-funded trials seek to shrink tumors in advanced casesContinue reading→

Continue reading→